DFX Intelligence

Allocator Intelligence

The capital-owner graph behind private markets. Who owns the capital, who decides, how much, under what policy, on whose advice, to which managers, and what changed, with a source and a date behind every row. A target is never an actual, a disclosed holding is never an approval, and an estimate says so.

Corporate pension

Glaxosmithkline Cash Balance Pension Plan

Corporate pensionPhiladelphia, PA
Assets
$2.9B
Total assets, Dec 31, 2024 reported
Funded
83.7%
Jan 1, 2024
Private markets target
n/a
policy Dec 31, 2024
Commitments
12
1 managers on Schedule C
Plan sponsor: Glaxosmithkline LLC
Allocation policy
Form 5500, as of Dec 31, 2024
Actual allocation lines without a target (as filed)
  • Non-interest-bearing cash 0.1%
  • Corporate debt instruments (other) 12.3%
  • Corporate debt instruments (preferred) 19.6%
  • U.S. Government securities 33.3%
  • Insurance company general account 0.4%
  • Other investments 0.1%
  • Partnership/joint venture interests 4.3%
  • Common/collective trusts 18.6%
  • Registered investment companies 4.2%
  • Common stock 1.8%
Consultants and advisers
4 firms
People
No investment staff or executives have been read for this allocator yet.
Manager roster
3 managers on the commitment tape
From the plan’s own commitment disclosures
From Schedule C (investment management, code 28)
Commitments
12 rows, 0 dated closings
Disclosed holdings (from the plan’s performance or holdings report, as of the report date)
DateFundManagerBucketAmountVintageStatusSource
as of Dec 31, 2024State Street Msci Eafe Index Non-Lecollective trustState Street - Russell 2000Pooled vehicles$93.1M heldDisclosed holdingaskebsa.dol.gov
as of Dec 31, 2024Daily Msci Emg Mkts Indx Nl Fundcollective trustState Street - Russell 2000Pooled vehicles$62.6M heldDisclosed holdingaskebsa.dol.gov
as of Dec 31, 2024Ssga Russell 3000 Index Nl Fundcollective trustState Street - Russell 2000Pooled vehicles$385M heldDisclosed holdingaskebsa.dol.gov
as of Dec 31, 2023Marathon-London International Fundcollective trustMarathon LondonPooled vehicles$56.7M heldDisclosed holdingaskebsa.dol.gov
as of Dec 31, 2023State Street Msci Eafe Index Non-Lecollective trustState Street - Russell 2000Pooled vehicles$70.9M heldDisclosed holdingaskebsa.dol.gov
as of Dec 31, 2023Daily Msci Emg Mkts Indx Nl Fundcollective trustState Street - Russell 2000Pooled vehicles$49.1M heldDisclosed holdingaskebsa.dol.gov
as of Dec 31, 2023Genesis Emerging Markets Fundcollective trustGenesis Asset Managers,llpPublic equity$447,824 heldDisclosed holdingaskebsa.dol.gov
as of Dec 31, 2023Ssga Russell 3000 Index Nl Fundcollective trustState Street - Russell 2000Pooled vehicles$334M heldDisclosed holdingaskebsa.dol.gov
as of Dec 31, 2022Marathon-London International Fundcollective trustMarathon LondonPooled vehicles$49.1M heldDisclosed holdingaskebsa.dol.gov
as of Dec 31, 2022State Street Msci Eafe Index Non-Lecollective trustState Street - Russell 2000Pooled vehicles$107M heldDisclosed holdingaskebsa.dol.gov
as of Dec 31, 2022Genesis Emerging Markets Fundcollective trustGenesis Asset Managers,llpPublic equity$46.5M heldDisclosed holdingaskebsa.dol.gov
as of Dec 31, 2022Ssga Russell 3000 Index Nl Fundcollective trustState Street - Russell 2000Pooled vehicles$274M heldDisclosed holdingaskebsa.dol.gov
Size and funding
33 readings
Total assets
$2.9B Dec 31, 2024 reported Form 5500
$2.9B (2023-12) · $2.8B (2022-12)
Plan assets
$2.9B Jan 1, 2024 reported Form 5500
$2.8B (2023-01) · $3.4B (2022-01)
Net assets
$2.9B Dec 31, 2024 reported Form 5500
$2.9B (2023-12) · $2.8B (2022-12)
Funded ratio
83.7% Jan 1, 2024 reported Form 5500
93.6% (2023-01) · 100.3% (2022-01)
Funding target
$3.0B Jan 1, 2024 reported Form 5500
$3.0B (2023-01) · $3.1B (2022-01)
Discount rate
4.96% Jan 1, 2024 reported Form 5500
5.09% (2023-01) · 5.24% (2022-01)
Participants
37,757 Jan 1, 2024 reported Form 5500
39,631 (2023-01) · 42,942 (2022-01)
Contributions
$131M Dec 31, 2024 reported Form 5500
$195M (2023-12) · $120M (2022-12)
Benefits paid
$310M Dec 31, 2024 reported Form 5500
$337M (2023-12) · $369M (2022-12)
Net investment income
$-33.6M Dec 31, 2024 reported Form 5500
$94.8M (2023-12) · $-589M (2022-12)
Investment management fees
$2.9M Dec 31, 2024 reported Form 5500
$3.7M (2023-12) · $3.8M (2022-12)
Form 5500 filings
3 plan years
Plan yearParticipantsAssets (SB market)Funding targetFTAPTotal assets (H)Partnerships / JVMaster trustReal estate
2024 to Dec 31, 202437,757$2.9B$3.0B83.7%$2.9B$124Mn/an/a
2023 to Dec 31, 202339,631$2.8B$3.0B93.6%$2.9B$145Mn/an/a
2022 to Dec 31, 202242,942$3.4B$3.1B100.3%$2.8B$168Mn/an/a
Service providers and investment entities as filed (Schedule C and D, latest year first)
What changed
7 events
  • Dec 31, 2024Holding endedinference
    Glaxosmithkline Cash Balance Pension Plan no longer reports Marathon-London International Fund (Marathon London) (last held $57M at 2023-12-31; absent from the 2024-12-31 filing)
    with Marathon Londonaskebsa.dol.gov
  • Dec 31, 2024Holding endedinference
    Glaxosmithkline Cash Balance Pension Plan no longer reports Genesis Emerging Markets Fund (Genesis Asset Managers,llp) (last held $447,824 at 2023-12-31; absent from the 2024-12-31 filing)
    with Genesis Asset Managers,llpaskebsa.dol.gov
  • Dec 31, 2024Manager relationship endedinference
    Genesis Asset Managers,llp no longer appears on Glaxosmithkline Cash Balance Pension Plan's Schedule C as investment manager (plan year 2024 vs 2023)
    with Genesis Asset Managers,llpaskebsa.dol.gov
  • Jan 1, 2024Funded status changed
    Glaxosmithkline Cash Balance Pension Plan funded ratio 93.6% -> 83.7% (2023-01-01 to 2024-01-01)
    askebsa.dol.gov
  • Dec 31, 2023Holding started
    Glaxosmithkline Cash Balance Pension Plan first reports an interest in Daily Msci Emg Mkts Indx Nl Fund (State Street - Russell 2000): $49M at 2023-12-31
    with State Street - Russell 2000askebsa.dol.gov
  • Jan 1, 2023Funded status changed
    Glaxosmithkline Cash Balance Pension Plan funded ratio 100.3% -> 93.6% (2022-01-01 to 2023-01-01)
    askebsa.dol.gov
  • Jan 1, 2023Assets changed
    Glaxosmithkline Cash Balance Pension Plan plan assets $3.4B -> $2.8B (-17.2%, 2022-01-01 to 2023-01-01)
    askebsa.dol.gov
Board record: approvals, recommendations, searches, terminations and re-up prospects for this system.
Provenance
Identifiers: EIN-PN 231099050-003
Cross-graph: no entry on another DFX graph
First observed Sep 15, 2026, last observed Sep 15, 2026. Classification confirmed. Every row above carries its source; a reported figure is the subject’s own, a derived one is arithmetic on reported figures, an estimated one is a model or a survey imputation and is never summed into a headline.